Charles Schwab Investment Management Inc Arvinas, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 530,669 shares of ARVN stock, worth $9.94 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
530,669
Previous 544,503
2.54%
Holding current value
$9.94 Million
Previous $14.5 Million
9.82%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding ARVN
# of Institutions
229Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$131 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$126 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$117 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$72.2 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$52.1 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $997M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...